VZL 2006, 75(3):120-125

Coffee from the View of Toxicologist

Veronika Petriková, Jiří Patočka ORCID...
Zdravotně sociální fakulta Jihočeské univerzity, České Budějovice

Káva je hojně konzumovaný nápoj, obvykle podávaný horký a připravovaný z pražených zrn kávovníku. Viděno prizmatem peněz, představuje káva druhou nejvýznamnější obchodní komoditu na světě, před níž je už jen nafta. Látky obsažené v kávě mají na zdraví lidí jen relativně malý účinek, ale veřejnost o nich často široce diskutuje. Káva je pro lidstvo nejvýznamnějším zdrojem kofeinu, látky se stimulačním účinkem. Kofein je nejpoužívanější psychoaktivní "drogou" a pravděpodobně nejrozšířenějším stimulantem ve sportu. Prospěšnost a nebezpečnost kávy byla a ještě dlouho bude široce studovaným a diskutovaným problémem. Předpokládá se např., že káva zvyšuje nebezpečí hypertenze. Smyslem tohoto článku je ukázat, jak na pití kávy pohlíží toxikolog.

Keywords: Káva; Kofein; Užitek; Nebezpečí; Toxikologie

Coffee is a widely consumed beverage, usually served hot, prepared from roasted seeds of a coffee plant. In terms of money, coffee is the second most traded commodity in the world, that is outclassed only by petroleum. Even though substances in coffee have relatively small health effects they are widely discussed by the public. Coffee is one of mankind's main sources of caffeine, compound with a stimulating effect. Caffeine is the most widely consumed psychoactive "drug" in the world and probably one of the most commonly used stimulants in sports. Its potential benefits and hazards have been, and continue to be, widely studied and discussed. For example it is supposed that caffeine in coffee increases the risk of hypertension. The aim of this paper is to present a view of toxicologist of drinking of coffee.

Keywords: Coffee; Caffeine; Benefit; Hazard; Toxicology

Received: March 27, 2006; Published: December 1, 2006  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Petriková, V., & Patočka, J. (2006). Coffee from the View of Toxicologist. Vojenské Zdravotnické Listy, 75(3-4), 120-125
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. BONNET, M., et al. Effects of caffeine on heart rate and QT variability during sleep. Depress. Anxiety, 2005, vol. 22, p. 150-155. Go to original source... Go to PubMed...
    2. BRODERICK, PJ. - BENJAMIN, AB. - DENIS, LW. Caffeine and psychiatric medication interactions: a review. J. Okla. State Med. Assoc., 2005, vol. 98, p. 380-384. Go to PubMed...
    3. CASTLE, TJ. - NIELSEN, J. The Great Coffee Book. USA, California, Ten Speed Press, 1999. 152 p. ISBN 1580081223
    4. DALVI, RR. Acute and chronic toxicity of caffeine: a review. Vet. Hum. Toxicol., 1986, vol. 28, p. 144-150. Go to PubMed...
    5. DOREA, JG. - da COSTA, TH. Is coffee a functional food? Br. J. Nutr., 2005, vol. 9, p. 773-782. Go to original source... Go to PubMed...
    6. ELLIS, F. Peasant Economics: Farm Households and Agrarian Development. 2nd ed. United Kingdom, Cambridge, 2000.
    7. FISONE, G. - BORGKVIST, A. - USIELLO, A. Caffeine as a psychomotor stimulant: mechanism of action. Cell. Mol. Life Sci., 2004, vol. 61, p. 857-872. Go to original source... Go to PubMed...
    8. FRANCA, AS. - MENDONCA, JCF. - OLIVEIRA, SD. Composition of green and roasted coffees of different cup qualities. LWT - Food Sci. Technik, 2005, vol. 38, p. 709-715. Go to original source...
    9. FREDHOLM, BB. Connection between caffeine, adenosine receptors and dopamine. Coffee reduces the risk of Parkinson disease. [Article in Swedish] Lakartidningen, 2004, vol. 101, p. 2552-2555. Go to PubMed...
    10. GOKUALKRISHNAN, S. - CHANDRARAJ, K. - GUMMADI, SN. Microbial and enzymatic methods for the removal of caffeine. Enzyme Microbiol. Technik, 2005, vol. 37, p. 225-232. Go to original source...
    11. CHEN, JF. The adenosine A(2A) receptor as an attractive target for Parkinson's disease treatment. Drug. News Perspect., 2003, vol. 16, p. 597-604. Go to original source... Go to PubMed...
    12. KHANDUJA, KL., et al. Anti-apoptotic activity of caffeic acid, ellagic acid and ferulic acid in normal human peripheral blood mononuclear cells: A Bcl-2 independent mechanism. Biochim. Biophys. Acta, Jan 17, 2006 [Epub ahead of print]. Go to original source... Go to PubMed...
    13. LODER, E. Fixed drug combinations for the acute treatment of migraine: place in therapy. CNS Drugs, 2005, vol. 19, p. 769-784. Go to original source... Go to PubMed...
    14. MAGKOS, F. - KAVOURAS, SA. Caffeine use in sports, pharmacokinetics in man, and cellular mechanisms of action. Crit. Rev. Food Sci. Nutr., 2005, vol. 45, p. 535-562. Go to original source... Go to PubMed...
    15. MARCZINSKI, CA. - FILLMORE, MT. Dissociative antagonistic effects of caffeine on alcohol-induced impairment of behavioral control. Exp. Clin. Psychopharmacol., 2003, vol. 11, p. 228-236. Go to original source... Go to PubMed...
    16. MAXOVÁ, D. - PATOČKA, J. Paracelsus a jeho význam pro současnost. Kontakt, 2004, roč. 6, s. 230-235.
    17. NAWROT, P., et al. Effects of caffeine on human health. Food Addit. Contam., 2003, vol. 20, p. 1-30. Go to original source... Go to PubMed...
    18. NOORDZIJ, M., et al. Blood pressure response to chronic intake of coffee and caffeine: a meta-analysis of randomized controlled trials. J. Hypertens, 2005, vol. 23, p. 921-928. Go to original source... Go to PubMed...
    19. NOTARIUS, CF. - MORRIS, BL. - FLORAS, JS. Caffeine attenuates early post-exercise hypotension in middle-aged subjects. Am. J. Hypertens., 2006, vol. 19, p. 184-188. Go to original source... Go to PubMed...
    20. PALUSKA, SA. Caffeine and exercise. Curr. Sports Med. Rep., 2003, vol. 2, p. 213-219. Go to original source... Go to PubMed...
    21. PANAGIOTAKOS, DB., et al. The association between coffee consumption and plasma total homocysteine levels: the "ATTICA" study. Heart Vessels., 2004, vol. 19, p. 280-286.
    22. SUDANO, I., et al. Cardiovascular effects of coffee: is it a risk factor? Prog. Cardiovasc. Nurs., 2005, vol. 20, p. 65-69. Go to original source... Go to PubMed...
    23. TIMSON, J. Caffeine. Mut. Res. Rev. Genet. Toxicol., 1977, vol. 47, p. 1-52. Go to original source... Go to PubMed...
    24. VAN DUSSELDORP, M. - KATAN, MB. -DEMECKER, PN. Effect of decaffeinated versus regular coffee on serum lipoproteins. A 12-week double-blind trial. Am. J. Epidemiol., 1990, vol. 132, p. 33-40. Go to original source... Go to PubMed...
    25. WINTGENS, JN. (Eds.) Coffee: Growing, Processing, Sustainable Production. A Guidebook for Growers, Processors, Traders, and Researchers. Germany, Weinheim, Wiley-VCH Verlag GmbH & Co., 2004. ISBN 3527307311. Go to original source...
    26. WU, T., et al. Caffeinated coffee, decaffeinated coffee, and caffeine in relation to plasma C-peptide levels, a marker of insulin secretion, in U.S. women. Diabetes Care, 2005, vol. 28, p. 1390-1396. Go to original source... Go to PubMed...

    Return to the content